XLON
0QYA
Market cap66bUSD
, Last price
Name
Celgene Corp
Chart & performance
P/E
—
P/S
—
EPS
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
13.35%
Revenues
Net income
CFO
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Related entities
Subsidiaries (3)
CELGENE INTERNATIONAL SÀRL
CELGENE LOGISTICS SÀRL
Key people
Chief Financial Officer, Executive Vice President · since 2018
President, Global Inflammation & Immunology Franchise · since 2017
President - Global Clinical Development · since 2018
President - Research and Early Development · since 2016
Executive Vice President, General Counsel · since 2018
Peter N. Kellogg
Executive Vice President and Chief Corporate Strategy Officer · since 2018
Jeffrey Galik
Treasurer · since 2019
IPO date
Jul 01, 1987
Employees
Domiciled in
US
Incorporated in
US
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
86 Morris Avenue
Summit, NJ 07901
US
Summit, NJ 07901
US
Valuation
No data to show